-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Serina Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2022 to 2024.
- Serina Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 10M shares, a 1.51% decline year-over-year.
- Serina Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 7.36M shares, a 0.11% increase from 2023.
- Serina Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 7.35M shares.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)